Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling

Mutation of the epidermal growth factor receptor (EGFR)

Our integrative approach provided a mechanistic description of the disorders of mutated EGFR signaling networks, which could facilitate the development of a systematic strategy toward controlling disease-related cell signaling.